Unaudited Financial Results for the quarter ended 30th June 2026.
1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.2) The Board Considered And Approved The Limited Review Report (Standalone & Consolidated) Of The Comp
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.
- Transgene Biotek Limited. Press Release Jul 23 2026
- Transgene Biotek Limited. Press Release Jul 22 2026
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Statement Of Deviation & Variation
Later from Transgene Biotek
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Transgene Biotek Limited. Press Release Aug 11 2026
- Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Wish To Inform You That The Company Has Received Approval From The Registrar Of Companies (ROC), Hyderabad, Telangana, For Extension Of Time
- Transgene Biotek Limited. Press Release Sep 25 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek